Key facts
- It has raised $1.3M; the latest was Early Stage VC in Mar 2026.
- Notable investors include Kinled Holding, Calm/Storm Ventures, Deuce Capital, YZR Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Univa
- ·The full record, as it builds
Funding rounds
No funding rounds for Univa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Univa
Developer of a digital health platform designed to manage, monitor, and treat eating disorders. The company's platform provides personalized digital care plans, dual applications for patients and carers, AI-driven health monitoring, data tracking, clinician dashboards for treatment planning and progress monitoring, integration of evidence-based therapeutic models such as family therapy and cognitive behavioral approaches, messaging and coaching support, and optional online therapy sessions, enabling healthcare providers, patients, and families to improve access to care, enhance treatment personalization, and support continuous recovery outcomes.
- Sector
- Healthcare
- HQ
- Worthing, United Kingdom
- Founded
- 2024
- Employees
- 6
- Website
- univa.health/
- Ownership
- Privately Held (backing)
Univa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Univa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Univa in its N-PORT filings yet. We sweep new filings monthly.